Brief: Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
27/02/2026 21:33
Feb 27 (Reuters) - Aardvark Therapeutics Inc AARD.O: AARDVARK THERAPEUTICS ANNOUNCES VOLUNTARY PAUSE OF PHASE 3 HERO TRIAL IN PRADER-WILLI SYNDROME AARDVARK THERAPEUTICS INC - PAUSE DUE TO CARDIAC OBSERVATIONS AT ABOVE TARGET DOSES AARDVARK THERAPEUTICS INC - TOPLINE DATA ANNOUNCEMENT DELAYED, GUIDANCE EXPECTED IN Q2 2026 Source text: ID:nGNX9KXxwy Further company coverage: AARD.O ((Reuters.Briefs@thomsonreuters.com;))